Hrt Financial LP Trevena Inc Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.41 - $0.63 $6,629 - $10,187	-16,170 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.29 $9,216 - $20,859	16,170 New	16,170 $9,000
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $1.1 Million - $1.7 Million	-753,374 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.77 - $2.93 $839,079 - $1.39 Million	474,056 Added 169.72%	753,374 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $522,041 - $798,993	245,090 Added 716.05%	279,318 $597,000
Q3 2020 Nov 13, 2020	BUY	$1.53 - $3.13 $2,867 - $5,865	1,874 Added 5.79%	34,228 $102,000
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.75 $15,529 - $56,619	32,354 New	32,354 $48,000
Q1 2019 May 14, 2019	SELL	$0.51 - $1.88 $12,410 - $45,749	-24,335 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$0.39 - $3.47 $9,490 - $84,442	24,335 New	24,335 $10,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.